The Kirby Institute would like to congratulate our PhD graduates, Dr Steve Badman and Dr Sasiwimol…
Category: News
PERSPECTIVES: Are integrase inhibitors the solution to HIV drug resistance in the Asia-Pacific region?
We asked four regional clinicians, researchers, and policy makers to share their reflections on whether integrase…
Dolutegravir: A Key HIV Drug That Too Many People Cannot Get
The integrase inhibitor dolutegravir (DTG) has shown great promise as a medicine to treat HIV since…
United Nations Under-Secretary-General and UNAIDS Executive Director Michel Sidibé visits her Royal Highness Princess Soamsawali of Thailand at Chulalongkorn Hospital
Bangkok, Thailand, 1 May 2019: United Nations Under-Secretary-General and UNAIDS Executive Director Michel Sidibé who was…
UNAIDS Recognizes the outstanding achievements of The Thai Red Cross AIDS Research Centre in evidence-based innovations
Bangkok, Thailand, 1 May 2019: A high-level event on ‘Advancing innovation in the HIV Response in…
TRCARC’s 30 years of journey to ending AIDS in Thailand
A lookback and ahead 30 years of our journey towards ending AIDS in Thailand
Unlock HIV self-testing kit in Thailand
Food and Drug Administration (FDA) collaborate with Department of Disease Control and Thai Red Cross AIDS…
Congratulations to Dr. Sasiwimol Ubolyam
Sasiwimol who has just been awarded her Doctrate for her work on tuberculosis immune-diagnostics and prognostics…
amfAR Researchers unable to find HIV in London transplant patient
SEATTLE, WA, March 5, 2019 – Researchers have reported that a stem cell transplant patient from…
Kirby Institute announces new Director
(Sydney, 31 January 2019) Leading international HIV researcher and clinician, Professor Anthony Kelleher, has been appointed…
IeDEA Asia-Pacific welcomes new Scientia PhD students to the Kirby Institute
The regional data center of IeDEA Asia-Pacific is at the Kirby Institute, University of New South…
Awards of Performance – REPREIVE study
On June 20, 2018, our site received two awards for its performance in the REPREIVE study.…